These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12296603)

  • 1. New global standards in lipid lowering: a review of emerging evidence and concepts.
    Olsson AG; Packard C
    Int J Clin Pract Suppl; 2002 Jul; (130):2-3. PubMed ID: 12296603
    [No Abstract]   [Full Text] [Related]  

  • 2. [LIMA-register: rationale, aims and design].
    Bestehorn K; Schäfer J; Gitt AK; Jannowitz C; Karmann B; Sonntag F; Weizel A
    MMW Fortschr Med; 2008 Sep; 150 Suppl 3():135-41. PubMed ID: 19025216
    [No Abstract]   [Full Text] [Related]  

  • 3. Regression of coronary artery disease as a result of intensive lipid-lowering therapy.
    N Engl J Med; 1991 Apr; 324(16):1133-5. PubMed ID: 2008188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lower coronary risk with aggressive cholesterol inhibition?].
    Hönl BS
    Med Monatsschr Pharm; 2006 Jun; 29(6):230-1. PubMed ID: 16792204
    [No Abstract]   [Full Text] [Related]  

  • 5. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive lipid-lowering therapy in high-risk groups: warranted or excessive?
    Wierzbicki AS
    Int J Clin Pract; 2003 May; 57(4):256-7. PubMed ID: 12800452
    [No Abstract]   [Full Text] [Related]  

  • 7. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol lowering drugs.
    Amarasingham R
    N Z Med J; 1990 Mar; 103(886):138. PubMed ID: 2181355
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical implications of clinical studies: can we compare different subgroups defined a posteriori?
    Vohnout B
    Eur Heart J; 2001 May; 22(9):798. PubMed ID: 11350113
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering cholesterol reduces mortality for heart patients with "normal" lipids.
    Harv Heart Lett; 1999 Feb; 9(6):5. PubMed ID: 10028898
    [No Abstract]   [Full Text] [Related]  

  • 14. Plant sterols and their role in combined use with statins for lipid lowering.
    Normén L; Holmes D; Frohlich J
    Curr Opin Investig Drugs; 2005 Mar; 6(3):307-16. PubMed ID: 15816508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study.
    Yoon YE; Rivera JJ; Kwon DA; Chae IH; Jeong MH; Rha SW; Blumenthal RS; Nasir K; Chang HJ;
    Prev Cardiol; 2009; 12(2):109-13. PubMed ID: 19476585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
    [No Abstract]   [Full Text] [Related]  

  • 20. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
    Brophy JM; Brassard P; Bourgault C
    Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.